Skip to content

LVX Medica

Active
Private limited company· 2 yrs active
Chaussée de Beaumont(BLW) 76 ·6440 Froidchapelle, Belgium
KBO/BCE: BE 0805.627.263
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age2 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of LVX Medica is 2.3% (moderate). The 2025 annual accounts show equity of €255k and a net result of €179k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Signals

1 signal · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

3 signals
Young company
Founded in 2023, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
2.3% Moderate
0%0,5%1,5%4%10%≥25%
Young company +No NACE activity registered +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€179k+146.3%
Working capital€244k+304.5%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 24-04-2026 with the NBB · fiscal year 2025 · micro
€0€100k€200k€300kOperating result 2024: €102k€102kNet result 2024: €73k€73kOperating result 2025: €256k€256kNet result 2025: €179k€179k20242025
Operating resultNet result
EBITDA
€261k
+145.4% 24-25
Net profit
€179k
+146.3% 24-25
Cash flow
€184k
+139.6% 24-25
Total assets
€284k
+240.8% 24-25
Equity
€255k
+236.5% 24-25
Working capital
€244k
+304.5% 24-25
Income taxes
€79k
+167.0% 24-25
Debt
€29k
+283.9% 24-25
Debt ≤ 1y
€29k
+283.9% 24-25
Current ratio
9.46
+4.8% 24-25
Quick ratio
9.46
+4.8% 24-25
Solvency
89.8%
-1.3% 24-25
Debt / equity
0.11
+14.1% 24-25
ROE
70.3%
-26.8% 24-25
ROA
63.1%
-27.7% 24-25
Interest coverage
1114.95
-85.3% 24-25
Figures by fiscal year
Fiscal year2025
Revenue-
EBITDA€261k
Net profit€179k
Cash flow€184k
Staff costs-
Income taxes€79k
Dividends-
Total assets€284k
Equity€255k
Debt€29k
of which ≤ 1y€29k
of which > 1y-
Working capital€244k
Employees (FTE)-
Ratios (computed)
2025
Current ratio9.46
Quick ratio9.46
Working capital ratio86.0%
Solvency89.8%
Debt / equity0.11
Long-term debt ratio-
Interest coverage1114.95
Gross margin-
Net margin-
ROA63.1%
ROE70.3%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€284k
Fixed assets 21/28€11k
Tangible fixed assets 22/27€11k
Current assets 29/58€273k
Amounts receivable within one year 40/41€6k
Investments 50/53€115k
Cash & bank 54/58€151k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€284k
Equity 10/15€255k
Contributions / capital 10/11€3k
Reserves 13€252k
Amounts payable 17/49€29k
Amounts payable within one year 42/48€29k
Trade debts payable within one year 44€28
Income statement
Gross operating margin 9900€261k
Operating result 9901€256k
Financial income 75€2k
Financial charges 65€234
Result before taxes 9903€258k
Income taxes 67/77€79k
Net result for the period 9904€179k
Result to be appropriated 9905€179k
You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
100 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
seat.Municipality exact location from the address register

Establishment units

1 location
LVX Medica
Chaussée de Beaumont(BLW) 76, 6440 FroidchapelleActiviteiten van medisch specialisten
since 20232.350.168.458
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area3,371 m²
Buildings1
Building footprint294 m²
Volume (LiDAR)1,800 m³
Tallest building8.9 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
56013A0888/00E000 Wallonia 3,371 m² 1 · 294 m² 8.9 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source and are complete.

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency100Growth78Stability82
92 / 100

Exceptional profile, strong across almost every axis.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 82

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Company registry

Company registry (CBE)

Crossroads Bank
Names & trade names
Legal nameFR LVX Medica
Registered office
Chaussée de Beaumont(BLW) 76
6440 Froidchapelle, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.